Comerica Bank Genmab A/S Transaction History

Comerica Bank

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$33.8 - $47.06 $31,873 - $44,377	-943 Reduced 4.44%	20,285 $0
Q3 2022 Oct 28, 2022	BUY	$31.52 - $373.61 $125,985 - $1.49 Million	3,997 Added 23.2%	21,228 $800,000
Q2 2022 Aug 02, 2022	SELL	$26.83 - $38.57 $2,200 - $3,162	-82 Reduced 0.47%	17,231 $616,000
Q1 2022 Apr 27, 2022	BUY	$30.95 - $39.68 $19,684 - $25,236	636 Added 3.81%	17,313 $626,000
Q4 2021 Feb 18, 2022	SELL	$35.87 - $47.12 $36,085 - $47,402	-1,006 Reduced 5.69%	16,677 $659,000
Q3 2021 Nov 22, 2021	SELL	$41.55 - $48.72 $1.09 Million - $1.27 Million	-26,140 Reduced 59.65%	17,683 $772,000
Q2 2021 Aug 26, 2021	SELL	$32.88 - $44.57 $9,436 - $12,791	-287 Reduced 0.65%	43,823 $1.79 Million
Q1 2021 Apr 28, 2021	BUY	$30.92 - $44.4 $77,763 - $111,666	2,515 Added 6.05%	44,110 $1.45 Million
Q4 2020 Jan 28, 2021	BUY	$33.66 - $40.76 $131,038 - $158,678	3,893 Added 10.33%	41,595 $1.69 Million
Q3 2020 Oct 30, 2020	SELL	$33.07 - $38.68 $33,764 - $39,492	-1,021 Reduced 2.64%	37,702 $1.38 Million
Q2 2020 Jul 31, 2020	BUY	$20.05 - $33.89 $25,623 - $43,311	1,278 Added 3.41%	38,723 $1.31 Million
Q1 2020 May 01, 2020	SELL	$17.15 - $25.22 $17,218 - $25,320	-1,004 Reduced 2.61%	37,445 $793,000
Q4 2019 Feb 07, 2020	BUY	$18.88 - $24.14 $17,822 - $22,788	944 Added 2.52%	38,449 $858,000
Q3 2019 Oct 31, 2019	BUY	$18.0 - $21.38 $675,090 - $801,856	37,505 New	37,505 $759,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.